BE1003578A4 - Nouvelles compositions ophtalmiques a base d'une cyclosporine. - Google Patents

Nouvelles compositions ophtalmiques a base d'une cyclosporine. Download PDF

Info

Publication number
BE1003578A4
BE1003578A4 BE8901138A BE8901138A BE1003578A4 BE 1003578 A4 BE1003578 A4 BE 1003578A4 BE 8901138 A BE8901138 A BE 8901138A BE 8901138 A BE8901138 A BE 8901138A BE 1003578 A4 BE1003578 A4 BE 1003578A4
Authority
BE
Belgium
Prior art keywords
sep
composition
eye
component
compositions
Prior art date
Application number
BE8901138A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1003578A4 publication Critical patent/BE1003578A4/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
BE8901138A 1988-10-26 1989-10-24 Nouvelles compositions ophtalmiques a base d'une cyclosporine. BE1003578A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26

Publications (1)

Publication Number Publication Date
BE1003578A4 true BE1003578A4 (fr) 1992-04-28

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8901138A BE1003578A4 (fr) 1988-10-26 1989-10-24 Nouvelles compositions ophtalmiques a base d'une cyclosporine.

Country Status (23)

Country Link
JP (1) JPH02164830A (cs)
KR (1) KR900005973A (cs)
AU (1) AU626928B2 (cs)
BE (1) BE1003578A4 (cs)
CA (1) CA2001502A1 (cs)
CH (1) CH679210A5 (cs)
DE (1) DE3935517A1 (cs)
DK (1) DK531289A (cs)
ES (1) ES2020032A6 (cs)
FI (1) FI895064A7 (cs)
FR (1) FR2638089A1 (cs)
GB (1) GB2224205B (cs)
GR (1) GR1000611B (cs)
HU (1) HU203046B (cs)
IL (1) IL92120A (cs)
LU (1) LU87613A1 (cs)
MY (1) MY106271A (cs)
NL (1) NL8902657A (cs)
NO (1) NO894266L (cs)
NZ (1) NZ231131A (cs)
PT (1) PT92120B (cs)
SE (1) SE8903583L (cs)
ZA (1) ZA898140B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
SG45449A1 (en) * 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
ATE218359T1 (de) 1994-11-03 2002-06-15 Novartis Erfind Verwalt Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
PT988046E (pt) 1997-01-30 2004-12-31 Novartis Ag Composicoes farmaceuticas sem oleo contendo ciclosporina a
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
MX2010004366A (es) * 2007-11-05 2010-05-05 Bausch & Lomb Materiales inmiscibles en agua como vehiculos para suministro de farmacos.
NO2437762T3 (cs) * 2009-06-05 2018-01-06
KR102487299B1 (ko) 2014-11-25 2023-01-10 알러간, 인코포레이티드 안정화된 오메가-3 안과용 조성물
MX381639B (es) 2016-12-23 2025-03-13 Novaliq Gmbh Composicion oftalmica para el tratamiento de la enfermedad del ojo seco.
CN114449999A (zh) 2019-09-06 2022-05-06 诺瓦利克有限责任公司 用于治疗葡萄膜炎的眼用组合物
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AMERICAN PHARMACEUTICAL ASSOCIATION/PHARMACEUTICAL SOCIETY OF GREAT BRITAIN: "Handbook of pharmaceutical excipients", 1986, pages 72,73,91,164,194,195, American Pharmaceutical Association, Washington, US *
H.P. FIEDLER: "Lexikon der Hilfstoffe f}r Pharmazie, Kosmetik und angrenzende Gebiete", vol. 1, A-K, 2ème édition, 1981, pages 120,121, Cantor, Aulendorf, DE *
R. VOIGT: "Lehrbuch der pharmazeutischen Technologie", 5ème édition, 1984, pages 339-341, Verlag Chemie, Weinheim, DE *

Also Published As

Publication number Publication date
AU626928B2 (en) 1992-08-13
SE8903583L (sv) 1990-04-27
NZ231131A (en) 1992-06-25
HUT52394A (en) 1990-07-28
GR1000611B (el) 1992-08-31
KR900005973A (ko) 1990-05-07
NO894266D0 (no) 1989-10-26
NO894266L (no) 1990-04-27
PT92120A (pt) 1990-04-30
SE8903583D0 (sv) 1989-10-26
HU203046B (en) 1991-05-28
DK531289A (da) 1990-04-27
DE3935517A1 (de) 1990-05-03
PT92120B (pt) 1995-06-30
ZA898140B (en) 1991-06-26
IL92120A0 (en) 1990-07-12
LU87613A1 (fr) 1991-05-07
HU895444D0 (en) 1990-01-28
GB2224205A (en) 1990-05-02
IL92120A (en) 1994-02-27
FI895064A0 (fi) 1989-10-25
JPH02164830A (ja) 1990-06-25
GB2224205B (en) 1992-04-15
MY106271A (en) 1995-04-29
NL8902657A (nl) 1990-05-16
GR890100690A (en) 1990-11-29
AU4371589A (en) 1990-05-03
FR2638089A1 (fr) 1990-04-27
ES2020032A6 (es) 1991-07-16
CH679210A5 (cs) 1992-01-15
DK531289D0 (da) 1989-10-25
GB8924040D0 (en) 1989-12-13
CA2001502A1 (en) 1990-04-26
FI895064A7 (fi) 1990-04-27

Similar Documents

Publication Publication Date Title
LU87613A1 (fr) Nouvelles compositions opthalmiques a base d'une cyclosporine
RU2048812C1 (ru) Способ лечения воспалительных заболеваний глаза и средство для лечения воспалительных заболеваний глаза
US20230398065A1 (en) Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
KR101656121B1 (ko) 안압 증가를 치료하기 위한 약학 조성물
US5294604A (en) Method of treating ocular diseases by periocular administration of cyclosporine A or G
IT8948485A1 (it) Composizioni oftalmiche a base di una ciclosporina (caso 600-7089)
CN1229136C (zh) 供局部施用于眼组织的泪腺特异性乳状液
KR0170769B1 (ko) 신규한 사이클로스포린 갈렌 제제
US12226422B2 (en) Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
EP2968139B1 (en) Microemulsion topical delivery platform
KR20070094600A (ko) 안질환 치료제
NL8902315A (nl) Farmaceutische preparaten die cyclosporinen bevatten.
JP2852057B2 (ja) 緑内症または高眼圧症治療剤
CN114449999A (zh) 用于治疗葡萄膜炎的眼用组合物
US4897421A (en) Ophthalmological composition of matter and a method for treatment of ocular inflammation by said composition
JP2019519479A (ja) 網膜神経変性疾患の眼局所治療のためのジペプチジルペプチダーゼ−４阻害剤
JP2023529190A (ja) シスチン症の治療
WO2021260430A1 (en) Use of high molecular weight hyaluronic acid as ocular transporting vehicle
JP4475802B2 (ja) 緑内障の局所治療用フルナリジンの使用法
van Sorge et al. Flurbiprofen, S (+), eyedrops: formulation, enantiomeric assay, shelflife and pharmacology
LEOPOLD et al. Intraocular penetration of locally applied steroids
US20230149337A1 (en) Ophthalmic formulation and its use
Arun Raj et al. Comparative Evaluation of Corneal Permeation of Indomethacin Using Different Vegetable Oil. Research & Reviews: A Journal of Pharmaceutical Science. 2021; 12 (2): 7–12p
Dilorenzo et al. Angiokeratoma corporis diffusum.(Fabry's disease).
FR2752736A1 (fr) Utilisation d'antagonistes 5-ht4 dans la regulation de la secretion de corticosteroides

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19941031